Fact Sheets and General Information About Genvoya
- Genvoya (elvitegravir + cobicistat + emtricitabine + tenofovir alafenamide) (AIDS InfoNet)
- Genvoya (Poz)
- Genvoya (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide) (Positively Aware)
- Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fumarate (Genvoya) (AIDSInfo) and Spanish version
- Genvoya Approval Notice (U.S. Food and Drug Administration)
- Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Now Included Among Recommended Regimens for Antiretroviral Treatment-Naive Individuals with HIV-1 Infection (November 2015, AIDSInfo)
Medications That Are Part of Genvoya
Genvoya is a combination pill that contains four different HIV drugs: elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide (TAF). Three of these four medications – elvitegravir, cobicistat, and emtricitabine – have also been approved for use as individual drugs.
To access the Health Library’s web pages on these drugs, please click on the following links:
For More Information
For news about recent studies or research involving Genvoya and the drugs it contains, you can go to the following web sites and search on the terms “Genvoya”, “elvitegravir”, “emtricitabine”, “tenofovir alafenamide”, “TAF”, “FTC”, “cobicistat”, “Emtriva”, “Viread”, “Vitekta”, or “Tybost”:
